| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | TENM2; KIAA1127; ODZ2; TNM2; Teneurin-2; Ten-2; Protein Odd Oz/ten-m homolog 2; Tenascin-M2; Ten-m2; Teneurin transmembrane protein 2 [Cleaved into: Ten-2, soluble form; Ten-2 intracellular domain; Ten-2 ICD] |
| Clonality | |
| Concentration | |
| Host | |
| Immunogen | E.coli-derived human TENM2 recombinant protein (Position: D1622-E2720). |
| Isotype | |
| Product Type | |
| Reactivity | |
| Reconstitution | |
| Target | |
| UniProt # |
Boster Bio Anti-TENM2 Antibody catalog # A12135. Tested in IHC, IF, Flow Cytometry, ELISA applications. This antibody reacts with Human.
Scientific background: Enables cell adhesion molecule binding activity and signaling receptor binding activity. Involved in retrograde trans-synaptic signaling by trans-synaptic protein complex. Located in cell-cell junction and plasma membrane.
Cross reactivity: No cross-reactivity with other proteins
Protein: Teneurin-2 | Gene: teneurin transmembrane protein 2 | Target: TENM2
Host: Rabbit | Clonality/Clone: Polyclonal | Isotype: Rabbit IgG | Reactivity: Human | Immunogen: E.coli-derived human TENM2 recombinant protein (Position: D1622-E2720). | Concentration: Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml. | Purification: Immunogen affinity purified.
Applications: WB, IHC, IF, ICC, FC, ELISA
Status: Active
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
